Decontamination of Prions by the Flowing Afterglow of a Reduced-pressure N2O2 Cold-plasma

Transmissible spongiform encephalopathies, also called prion diseases, represent a family of neurodegenerative disorders that affect various animal species. Since the infectious forms of prions are transmissible and highly resistant to chemical and physical decontamination methods routinely used in healthcare, they represent a challenge for science, medicine, and public health/food systems. Suitable decontamination procedures have been proposed, but they are generally incompatible with the materials from which medical devices are made. In this study, we evaluate a cold gaseous-plasma treatment, based on the outflow from a N 2 ―O 2 microwave discharge, as an alternative decontamination tool against both the non-infectious (PrP C ) and infectious (PrP Sc ) forms of prion proteins. The efficiency of the plasma treatment on these proteins is assessed using an in vitro assay as well as an in vivo bioassay. We showed by Enzyme-Linked Immuno-Sorbent Assay (ELISA) that n the N 2 ―O 2 discharge afterglow reduces the immunoreactivity of both non-infectious recombinant and pathogenic prion proteins deposited on polystyrene substrates. Tests done in vivo demonstrate that exposure to the cold-plasma flowing afterglow achieves significant decontamination of stainless steel sutures inoculated with infectious forms of prions to be implanted in mice.

[1]  Michael G. Kong,et al.  Protein destruction by a helium atmospheric pressure glow discharge: Capability and mechanisms , 2007 .

[2]  X. Roucou,et al.  Neuroprotective functions of prion protein , 2004, Journal of neuroscience research.

[3]  A. Simpson,et al.  Elimination of transmissible spongiform encephalopathy infectivity and decontamination of surgical instruments by using radio-frequency gas-plasma treatment. , 2005, The Journal of general virology.

[4]  Andrew F. Hill,et al.  The same prion strain causes vCJD and BSE , 1997, Nature.

[5]  J. Collinge,et al.  A standardized comparison of commercially available prion decontamination reagents using the Standard Steel-Binding Assay , 2011, The Journal of general virology.

[6]  O. Janoušková,et al.  Inactivation of Prions Using Electrical DC Discharges at Atmospheric Pressure and Ambient Temperature , 2011 .

[7]  M. Moisan,et al.  Influence of Substrate Materials on Inactivation of B. atrophaeus Endospores in a Reduced‐pressure Argon Plasma , 2011 .

[8]  P. Coelho,et al.  Modelling of a post-discharge reactor used for plasma sterilization , 2006 .

[9]  A. Osman,et al.  Immunoquantitative PCR for prion protein detection in sporadic Creutzfeldt-Jakob disease. , 2005, Clinical chemistry.

[10]  Detlev Riesner,et al.  Biochemistry and structure of PrP(C) and PrP(Sc). , 2003, British medical bulletin.

[11]  B. Saoudi,et al.  Characterization of the flowing afterglows of an N2–O2 reduced-pressure discharge: setting the operating conditions to achieve a dominant late afterglow and correlating the NOβ UV intensity variation with the N and O atom densities , 2007 .

[12]  D. Taylor,et al.  Survival of scrapie agent after exposure to sodium dodecyl sulphate and heat. , 1999, Veterinary microbiology.

[13]  B. Saoudi,et al.  Modelling the Low‐Pressure N2 ? O2 Plasma Afterglow to Determine the Kinetic Mechanisms Controlling the UV Emission Intensity and Its Spatial Distribution for Achieving an Efficient Sterilization Process , 2008 .

[14]  Michel Moisan,et al.  Plasma sources using long linear microwave field applicators: main features, classification and modelling , 1995 .

[15]  S. Prusiner,et al.  Thiocyanate and hydroxyl ions inactivate the scrapie agent. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Ross,et al.  A Mutant Ataxin-3 Putative-Cleavage Fragment in Brains of Machado-Joseph Disease Patients and Transgenic Mice Is Cytotoxic above a Critical Concentration , 2004, The Journal of Neuroscience.

[17]  S. Prusiner,et al.  Purified scrapie prions resist inactivation by UV irradiation , 1987, Journal of virology.

[18]  J. Collinge,et al.  Transmission of Scrapie by Steel-surface-bound Prions , 2001, Molecular medicine.

[19]  A. Yanguas-Gil,et al.  Inactivation of Bacteria and Biomolecules by Low-Pressure Plasma Discharges , 2010 .

[20]  Martin Polak,et al.  Low temperature atmospheric pressure plasma sources for microbial decontamination , 2011 .

[21]  G. De Crescenzo,et al.  Validation of cold plasma treatment for protein inactivation: a surface plasmon resonance-based biosensor study , 2006 .

[22]  D. Taylor Inactivation of the unconventional agents of scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. , 1991, The Journal of hospital infection.

[23]  M Moreau,et al.  Non-thermal plasma technologies: new tools for bio-decontamination. , 2008, Biotechnology advances.

[24]  B. Caughey Prion protein interconversions. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[25]  S. Prusiner Novel proteinaceous infectious particles cause scrapie. , 1982, Science.

[26]  W A Rutala,et al.  Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  K. Roth,et al.  Inactivation of Animal and Human Prions by Hydrogen Peroxide Gas Plasma Sterilization , 2009, Infection Control & Hospital Epidemiology.

[28]  C. Weissmann,et al.  Molecular Genetics of Transmissible Spongiform Encephalopathies* , 1999, The Journal of Biological Chemistry.

[29]  S. Moreau,et al.  Low-temperature sterilization using gas plasmas: a review of the experiments and an analysis of the inactivation mechanisms. , 2001, International journal of pharmaceutics.

[30]  K. Roth,et al.  Infectivity of Prion Protein Bound to Stainless Steel Wires: A Model for Testing Decontamination Procedures for Transmissible Spongiform Encephalopathies , 2004, Infection Control & Hospital Epidemiology.

[31]  D. Taylor Inactivation of transmissible degenerative encephalopathy agents: A review. , 2000, Veterinary journal.

[32]  J. Collinge,et al.  An enzyme-detergent method for effective prion decontamination of surgical steel. , 2005, The Journal of general virology.

[33]  S. Prusiner,et al.  Inactivation of Prions by Acidic Sodium Dodecyl Sulfate , 2006, Journal of Virology.

[34]  O. Kylián,et al.  Removal of Model Proteins Using Beams of Argon Ions, Oxygen Atoms and Molecules : Mimicking the Action of Low-Pressure Ar/O2 ICP Discharges , 2009 .

[35]  M. Palmer,et al.  Prion protein is necessary for normal synaptic function , 1994, Nature.

[36]  J. Collinge,et al.  Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces , 2009, Proceedings of the National Academy of Sciences.

[37]  D. Harris,et al.  The cellular prion protein (PrP(C)): its physiological function and role in disease. , 2007, Biochimica et biophysica acta.

[38]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[39]  M. Chaker,et al.  Influence of the field frequency on the nitrogen atom yield in the remote plasma of an high frequency discharge , 1998 .

[40]  A. Jenny,et al.  Use of capillary sodium dodecyl sulfate gel electrophoresis to detect the prion protein extracted from scrapie-infected sheep. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[41]  T. Alper,et al.  Further Studies on the Inactivation of the Scrapie Agent by Ultraviolet Light , 1969 .

[42]  O. Kylián,et al.  Low pressure plasma discharges for the sterilization and decontamination of surfaces , 2009 .

[43]  P. Coelho,et al.  Active species in a large volume N2–O2 post-discharge reactor , 2007 .

[44]  B. Saoudi,et al.  The respective roles of UV photons and oxygen atoms in plasma sterilization at reduced gas pressure: the case of N/sub 2/-O/sub 2/ mixtures , 2002 .

[45]  M. Enari,et al.  Infectivity of Scrapie Prions Bound to a Stainless Steel Surface , 1999, Molecular medicine.

[46]  P. Brown,et al.  Novel methods for disinfection of prion-contaminated medical devices , 2004, The Lancet.